Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

LENSAR's Ally Laser Cataract System cleared by FDA: Parkhurst NuVision will be among the first in US to offer


News provided by

Parkhurst NuVision

Jun 13, 2022, 12:00 ET

Share this article

Share toX

Share this article

Share toX

Parkhurst NuVision
Parkhurst NuVision

The Ally Lensar Laser cleared by the FDA for use in the United States.

SAN ANTONIO, June 13, 2022 /PRNewswire-PRWeb/ -- The Ally Lensar laser is a cataract treatment system that combines a femtosecond laser for cataract surgery with phacoemulsification in a single medical device. Phacoemulsification, which uses ultrasound technology, has been the gold-standard for cataract surgery since the early 1980's, whereas femtosecond laser systems for eye surgery were originally used in LASIK in the early 2000's, and then later developed to be used alongside phacoemulsification during cataract surgery. This is a landmark achievement in ophthalmology that these two proven systems for cataract surgery are now married together within a single piece of technology. The Ally laser cataract system will deliver safe and effective cataract surgery for patients suffering from blurry vision due to cataracts, likely for generations to come.

Since cataracts are the world's leading cause of treatable blindness, cataract surgery is the single most common surgical procedure performed in the United States. As a clinical researcher and member of the LENSAR Medical Advisory Board, Dr. Gregory Parkhurst at Parkhurst NuVision in San Antonio is excited to lead one of the first cataract surgery practices in the United States to offer the Ally laser to his patients needing cataract surgery.

"As a Lensar Medical Advisory Board Member, clinical researcher and scientist, I was honored to help LENSAR, develop the ALLY System. With FDA clearance, I look forward to providing next-gen laser cataract surgery to my patients,” said Gregory Parkhurst, MD.

Post this

"As a Lensar Medical Advisory Board Member, clinical researcher and scientist, I was honored to help LENSAR, develop the ALLY System. With FDA clearance, I look forward to providing next-gen laser cataract surgery to my patients," said Gregory Parkhurst, MD.

Cataracts occur when there is a clouding of the natural lens of the eye, often due to aging, years of UV-light exposure, and/or lack of adequate nutrition. While cataract surgery San Antonio patients are common, approximately 10 million cataract surgeries are performed globally on an annual basis.

"The ability to combine phaco and a new LENSAR laser into a single adaptive system for use in the operating room will make cataract surgery easier for patents and eye surgeons alike. This reminds me of when we used to have 3 or 4 handheld devices (a blackberry calendar, a GPS, a camera, and a cell phone) before smart phones came along and combined all of those technologies into a single device," said Dr. Parkhurst. "The Ally system is the next evolution in cataract surgery and will change the way cataract surgery is done world-wide for the next generation of patients and surgeons."

Laser cataract surgery is a quick and effective procedure that offers many benefits. The Ally system can be used to remove cataracts and also correct vision problems like astigmatism; together with specialized lenses, even eliminate the need for glasses, including reading glasses and bifocals after cataract surgery. The Ally LENSAR laser may be an ideal option for ophthalmologists who want to provide vision correction along with cataract treatment, without having to invest, maintain, and find floor space for multiple pieces of medical equipment in their operating suites.

Because no two cataracts or vision needs are exactly alike, each individual patient needs to understand the benefits and potential risks of any cataract or vision correction procedure. A virtual-online or in-person consultation with an eye doctor at Parkhurst NuVision in San Antonio can give you the information you need to make an informed decision on vision correction procedures and cataract surgery.

ABOUT PARKHURST NUVISION
Parkhurst NuVision is widely known as a premier vision correction surgery center and clinical research facility. The group practice was founded by award-winning and board-certified ophthalmologist, Dr. Gregory Parkhurst, who is the Physician CEO of Parkhurst NuVision. Parkhurst NuVision was the first designated LENSAR laser center of Excellence in the United States in 2014, and proudly serves the community of San Antonio, Texas, as well as the many patients who travel from across the nation for our expertise in cataract and vision correction surgery. As a leader in personalized eye surgery, we are committed to offering the full range of vision correction solutions, including EVO Visian ICL, LASIK, SMILE LASIK, PRK, Laser Lens Treatment (RLE), and Laser Cataract Surgery. Whatever your type of cataract or stage in life, the team at Parkhurst NuVision is here to help you achieve your best vision ever and improve your overall quality of life. https://sanantonio-lasik.com/

# # #
Contact:
Parkhurst NuVision
9725 Datapoint Dr
Ste 106
San Antonio, TX 78229
(336) 508-4447
Contact Name: Angie Kruse
Email: [email protected]

Media Contact

Amanda Kincaid, Parkhurst NuVision, +1 2108184116, [email protected]

Twitter

SOURCE Parkhurst NuVision

Modal title

LENSAR’s Ally Laser Cataract System cleared by FDA: Parkhurst NuVision will be among the first in US to offer
View PDF
LENSAR’s Ally Laser Cataract System cleared by FDA: Parkhurst NuVision will be among the first in US to offer
LENSAR’s Ally Laser Cataract System cleared by FDA: Parkhurst NuVision will be among the first in US to offer

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.